Inovio Pharma Inks $100M Stock Sales Agreement with Stifel

Inovio Pharmaceuticals (NYSEMKT:INO) enters into an at-the-market deal with Stifel, Nicholas & Co. for the sale of up to $100M of its common stock. Stifel will earn a 3% commission for its efforts.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.